BlackRock’s Accretive Health AH Stock Holding History

BlackRock’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1,550	Closed	-$14K	–	3222
2013 Q4	$14K	Hold	1,550	–	–	﹤0.01%	2552
2013 Q3	$14K	Hold	1,550	–	–	﹤0.01%	2475
2013 Q2	$17K	Buy	+1,550	New	+$16.3K	﹤0.01%	2397

Other funds holding AH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JRP

Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

BlackRock's AH Position: Q1 2014 in Review

BlackRock sold out of Accretive Health (AH) in Q1 2014, closing a stake of 1,550 shares — an estimated $14K sold.

BlackRock first reported a position in AH in Q2 2013 and held it in 3 quarters. The position peaked at $17K in Q2 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

BlackRock reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
BlackRock sold 1,550 Accretive Health shares in Q1 2014, an estimated $14K.
BlackRock first reported a position in Accretive Health in Q2 2013 and held it in 3 quarters.
BlackRock's Accretive Health position peaked at $17K in Q2 2013.
66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on BlackRock's 13F filing for Q1 2014, filed 2 May 2014.